Myeloma, amyloidosis, macroglobulinemia and other gammapathies
Featured publications
-
Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia
Moreno, David F; Lopez-Guerra, Monica; Paz, Sara; Oliver-Caldes, Aina; Mena, Mari-Pau;(...)Jimenez-Segura, Raquel; Blade, Joan; Rosinol, Laura; Colomer, Dolors; Fernandez de Larrea, Carlos.Reference:British Journal Of Haematology 2023.
-
T cells isolated from G-CSF-treated multiple myeloma patients are suitable for the generation of BCMA-directed CAR-T cells
Battram, AM; Oliver-Caldés, A; Suárez-Lledó, M; Crespo, MBI; Martínez-Cibrián, N;(...)Moreno, DF; Rodríguez-Lobato, LG; Urbano-Ispizua, A; de Larrea, CF; Lozano, M.Reference:Molecular Therapy-Methods & Clinical Development 2022.
-
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage
Fernandez de Larrea, Carlos; Kyle, Robert; Rosinol, Laura; Paiva, Bruno; Engelhardt, Monika;(...)Kaiser, Martin; San Miguel, Jesus; Blade, Joan; Rajkumar, S Vincent; Victoria Mateos, Maria.Reference:Blood Cancer Journal 2021.
-
Gene Expression Analysis of the Bone Marrow Microenvironment Reveals Distinct Immunotypes in Smoldering Multiple Myeloma Associated to Progression to Symptomatic Disease
Isola, Ignacio; Braso-Maristany, Fara; Moreno, David F; Mena, Mari-Pau; Oliver-Calders, Aina;(...)Blade, Joan; Rosinol, Laura; Prat, Aleix; Lozano, Ester; Fernandez de Larrea, Carlos.Reference:Frontiers In Immunology 2021.
-
Treatment of Patients with Monoclonal Gammopathy of Clinical Significance
Moreno, David F; Rosinol, Laura; Teresa Cibeira, Maria; Blade, Joan; Fernandez de Larrea, Carlos;Reference:Cancers 2021.
-
Defining an Ultra-Low Risk Group in Asymptomatic IgM Monoclonal Gammopathy
Moreno, David F; Pereira, Arturo; Tovar, Natalia; Cibeira, Maria Teresa; Magnano, Laura;(...)Oliver-Caldes, Aina; Mena, Mari Pau; Rosinol, Laura; Blade, Joan; Fernandez de Larrea, Carlos.Reference:Cancers 2021.
-
Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure
Uribe-Herranz, Mireia; Klein-Gonzalez, Nela; Rodriguez-Lobato, Luis Gerardo; Juan, Manel; Fernandez de Larrea, Carlos;Reference:International Journal Of Molecular Sciences 2021.
-
Nectin-2 expression on malignant plasma cells is associated with better response to TIGIT blockade in multiple myeloma
Lozano, Ester; Mena, Mari-Pau; Diaz, Tania; Martin-Antonio, Beatriz; Leon, Sheila;(...)Teresa Cibeira, Maria; Blade, Joan; Prat, Aleix; Rosinol, Laura; Fernandez de Larrea, Carlos.Reference:Clinical Cancer Research 2020.
-
Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression
Fernandez de Larrea, Carlos; Isola, Ignacio; Pereira, Arturo; Teresa Cibeira, Ma; Magnano, Laura;(...)Lozano, Ester; Rozman, Maria; Yague, Jordi; Blade, Joan; Rosinol, Laura;.Reference:Leukemia 2018.
-
Bone marrow plasma cell infiltration in light chain amyloidosis: impact on organ involvement and outcome.
Tovar N; Rodríguez-Lobato LG; Cibeira MT; Magnano L; Isola I;Rosiñol L; Bladé J; Fernández de Larrea C .Reference:Amyloid-Journal Of Protein Folding Disorders 2018.